• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响肺循环压力和容量的变量是高原肺水肿(HAPE)发生的危险因素。

Variables Influencing the Pressure and Volume of the Pulmonary Circulation as Risk Factors for Developing High Altitude Pulmonary Edema (HAPE).

机构信息

Institute of Occupational & Social Medicine, RWTH Aachen Technical University, 52074 Aachen, Germany.

Department of Operative Dentistry, Periodontology & Preventive Dentistry, RWTH Aachen Technical University, 52074 Aachen, Germany.

出版信息

Int J Environ Res Public Health. 2022 Oct 26;19(21):13887. doi: 10.3390/ijerph192113887.

DOI:10.3390/ijerph192113887
PMID:36360767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9658762/
Abstract

BACKGROUND

At altitudes above 2500 m, the risk of developing high altitude pulmonary edema (HAPE) grows with the increases in pulmonary arterial pressure. HAPE is characterized by severe pulmonary hypertension, though the incidence and relevance of individual risk factors are not yet predictable. However, the systolic pulmonary pressure (SPAP) and peak in tricuspid regurgitation velocity (TVR) are crucial factors when diagnosing pulmonary hypertension by echocardiography.

METHODS

The SPAP and TVR of 27 trekkers aged 20-65 years en route to the Solu Khumbu region of Nepal were assessed. Echocardiograph measurements were performed at Lukla (2860 m), Gorak Shep (5170 m), and the summit of Kala Patthar (5675 m). The altitude profile and the participants' characteristics were also compiled for correlation with the measured data.

RESULTS

The results showed a highly significant increase in SPAP and TVR after ascending Kala Patthar. The study revealed a lower increase of SPAP and TVR in the group of older participants, although the respective initial measurements at Gorak Shep were significantly higher for this group. A similar finding occurred in those using Diamox as prophylaxis. There was an inverse relationship between TVR and SPAP, the peripheral capillary oxygen saturation, and heart rate.

CONCLUSIONS

The echocardiograph results indicated that older people are an at-risk group for developing HAPE. A conservative interpretation of the basic tactical rules for altitudes should be followed for older trekkers or trekkers with known problems of altitude acclimatization ("slow acclimatizer") as SPAP elevates with age. The prophylactic use of Acetazolamide (Diamox) should be avoided where not necessary for acute medical reasons. Acetazolamide leads to an increase of SPAP, and this may potentially enhance the risk of developing HAPE. Arterial oxygen saturation measurements can provide an indicator for the self-assessment for the risk of developing HAPE and a rule of thumb for the altitude profile, but does not replace a HAPE diagnosis. Backpack weight, sex, workload (actual ascent speed), and pre-existing diseases were not statistically significant factors related to SPAP and TVR ( ≤ 0.05).

摘要

背景

在海拔 2500 米以上的高度,肺动脉压升高会增加发生高原肺水肿(HAPE)的风险。HAPE 的特征是严重的肺动脉高压,尽管个体危险因素的发生率和相关性尚无法预测。然而,通过超声心动图诊断肺动脉高压时,收缩期肺动脉压(SPAP)和三尖瓣反流速度峰值(TVR)是至关重要的因素。

方法

对 27 名年龄在 20-65 岁之间的徒步旅行者在前往尼泊尔索鲁昆布地区的途中的 SPAP 和 TVR 进行评估。在卢卡拉(2860 米)、戈拉克谢普(5170 米)和卡拉帕塔尔峰(5675 米)进行超声心动图测量。还编制了海拔剖面图和参与者特征,以与测量数据相关联。

结果

结果显示,攀登卡拉帕塔尔峰后 SPAP 和 TVR 显著升高。研究表明,年龄较大的参与者 SPAP 和 TVR 的升高幅度较低,尽管该组在戈拉克谢普的初始测量值明显较高。使用 Diamox 作为预防措施的人也有类似的发现。TVR 与 SPAP、外周毛细血管血氧饱和度和心率呈负相关。

结论

超声心动图结果表明,老年人是发生 HAPE 的高危人群。对于年龄较大的徒步旅行者或已知对高原适应有问题的徒步旅行者(“适应较慢者”),应遵循对高海拔基本战术规则的保守解释,因为 SPAP 会随年龄增长而升高。在没有急性医疗原因的情况下,应避免不必要地使用乙酰唑胺(Diamox)进行预防。乙酰唑胺会导致 SPAP 升高,这可能会增加发生 HAPE 的风险。动脉血氧饱和度测量值可以为评估发生 HAPE 的风险提供指标,并为海拔剖面提供经验法则,但不能替代 HAPE 诊断。背包重量、性别、工作量(实际上升速度)和既往疾病不是与 SPAP 和 TVR 相关的统计学显著因素(≤0.05)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/cc070b6addce/ijerph-19-13887-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/3224a92e2d29/ijerph-19-13887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/37b2615321d3/ijerph-19-13887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/5bbb023a8c5b/ijerph-19-13887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/0af6d9db0ccd/ijerph-19-13887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/cc070b6addce/ijerph-19-13887-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/3224a92e2d29/ijerph-19-13887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/37b2615321d3/ijerph-19-13887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/5bbb023a8c5b/ijerph-19-13887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/0af6d9db0ccd/ijerph-19-13887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9385/9658762/cc070b6addce/ijerph-19-13887-g005.jpg

相似文献

1
Variables Influencing the Pressure and Volume of the Pulmonary Circulation as Risk Factors for Developing High Altitude Pulmonary Edema (HAPE).影响肺循环压力和容量的变量是高原肺水肿(HAPE)发生的危险因素。
Int J Environ Res Public Health. 2022 Oct 26;19(21):13887. doi: 10.3390/ijerph192113887.
2
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.乙酰唑胺对快速主动上升至4559米后肺动脉压及高原肺水肿预防的影响。
J Appl Physiol (1985). 2022 Jun 1;132(6):1361-1369. doi: 10.1152/japplphysiol.00806.2021. Epub 2022 May 5.
3
Trends in the workload of the two high altitude aid posts in the Nepal Himalayas.尼泊尔喜马拉雅地区两个高海拔援助站的工作量趋势。
J Travel Med. 1999 Dec;6(4):217-22. doi: 10.1111/j.1708-8305.1999.tb00521.x.
4
Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.乙酰唑胺无法降低部分适应高原环境的人群在高海拔地区的肺动脉压力。
High Alt Med Biol. 2008 Fall;9(3):209-16. doi: 10.1089/ham.2007.1073.
5
Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor.高原肺水肿的发病机制:炎症并非病因。
JAMA. 2002 May 1;287(17):2228-35. doi: 10.1001/jama.287.17.2228.
6
Patent foramen ovale and high-altitude pulmonary edema.卵圆孔未闭与高原肺水肿
JAMA. 2006 Dec 27;296(24):2954-8. doi: 10.1001/jama.296.24.2954.
7
[Pathophysiology, prevention and therapy of altitude pulmonary edema].高原肺水肿的病理生理学、预防与治疗
Schweiz Med Wochenschr. 1992 Aug 4;122(31-32):1151-8.
8
Doppler assessment of pulmonary hypertension induced by hypoxic breathing in subjects susceptible to high altitude pulmonary edema.对易患高原肺水肿的受试者进行低氧呼吸诱导的肺动脉高压的多普勒评估。
Am Rev Respir Dis. 1990 Oct;142(4):796-801. doi: 10.1164/ajrccm/142.4.796.
9
Delayed-Onset High Altitude Pulmonary Edema: A Case Report.迟发性高原肺水肿:一例报告
Wilderness Environ Med. 2019 Mar;30(1):90-92. doi: 10.1016/j.wem.2018.11.002. Epub 2019 Jan 11.
10
High altitude pulmonary edema in children: A systematic review.儿童高原肺水肿:一项系统评价。
Pediatr Pulmonol. 2023 Apr;58(4):1059-1067. doi: 10.1002/ppul.26294. Epub 2022 Dec 29.

引用本文的文献

1
Curcumin supplementation accelerates high-altitude acclimatization, prevents polycythemia and modulates gut microbiota in male Han population: a randomized controlled trial.补充姜黄素可加速汉族男性人群的高原适应,预防红细胞增多症并调节肠道微生物群:一项随机对照试验。
Front Nutr. 2025 Jul 8;12:1572376. doi: 10.3389/fnut.2025.1572376. eCollection 2025.
2
The impact of high-altitude and cold environment on brain and heart damage in rats with hemorrhagic shock.高原寒冷环境对失血性休克大鼠脑和心脏损伤的影响
Brain Circ. 2024 Jun 26;10(2):174-183. doi: 10.4103/bc.bc_24_24. eCollection 2024 Apr-Jun.
3
Anesthesia strategies for elderly patients with craniocerebral injury due to foreign-body penetration in the plateau region: a case report.

本文引用的文献

1
Efficacy of acetazolamide for the prophylaxis of acute mountain sickness: A systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials.乙酰唑胺预防急性高原病的疗效:一项随机临床试验的系统评价、荟萃分析和试验序贯分析
Ann Thorac Med. 2021 Oct-Dec;16(4):337-346. doi: 10.4103/atm.atm_651_20. Epub 2021 Oct 26.
2
Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).降低乙酰唑胺剂量预防高原病:62.5毫克与125毫克的比较(RADICAL试验)
Wilderness Environ Med. 2019 Mar;30(1):12-21. doi: 10.1016/j.wem.2018.09.002. Epub 2019 Jan 8.
3
高原地区异物穿透性颅脑损伤老年患者的麻醉策略:一例报告
Front Med (Lausanne). 2024 May 13;11:1385603. doi: 10.3389/fmed.2024.1385603. eCollection 2024.
4
Initial Treatment of High-Altitude Pulmonary Edema: Comparison of Oxygen and Auto-PEEP.高原性肺水肿的初始治疗:氧气与自动 PEEP 的比较。
Int J Environ Res Public Health. 2022 Dec 3;19(23):16185. doi: 10.3390/ijerph192316185.
Echocardiographic assessment of cardiac performance in response to high altitude and development of subclinical pulmonary edema in healthy climbers.
超声心动图评估健康登山者对高原环境的心脏功能反应及亚临床性肺水肿的发生情况。
Can J Cardiol. 2013 Oct;29(10):1277-84. doi: 10.1016/j.cjca.2013.04.025. Epub 2013 Jul 17.
4
Linear regression analysis: part 14 of a series on evaluation of scientific publications.线性回归分析:系列评估科学出版物之十四。
Dtsch Arztebl Int. 2010 Nov;107(44):776-82. doi: 10.3238/arztebl.2010.0776. Epub 2010 Nov 5.
5
The impact of moderate-altitude staging on pulmonary arterial hemodynamics after ascent to high altitude.中海拔停留对高海拔上升后肺动脉血液动力学的影响。
High Alt Med Biol. 2010 Summer;11(2):139-45. doi: 10.1089/ham.2009.1073.
6
[Diagnosis and treatment of pulmonary hypertension: European guidelines 2009].《肺动脉高压的诊断与治疗:2009年欧洲指南》
Pneumologie. 2010 Jul;64(7):401-14. doi: 10.1055/s-0029-1244112. Epub 2010 May 18.
7
[Aging with mental impairment--basic theoretical principles: recognizing physiologic aging].伴有精神障碍的衰老——基本理论原则:认识生理性衰老
Pflege Z. 2008 Oct;61(10):544-7.
8
Clinical features of patients with severe altitude illness in Nepal.尼泊尔严重高原病患者的临床特征。
J Travel Med. 2008 Sep-Oct;15(5):315-22. doi: 10.1111/j.1708-8305.2008.00229.x.
9
Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.乙酰唑胺无法降低部分适应高原环境的人群在高海拔地区的肺动脉压力。
High Alt Med Biol. 2008 Fall;9(3):209-16. doi: 10.1089/ham.2007.1073.
10
High-altitude pulmonary edema is initially caused by an increase in capillary pressure.高原肺水肿最初是由毛细血管压力升高引起的。
Circulation. 2001 Apr 24;103(16):2078-83. doi: 10.1161/01.cir.103.16.2078.